Young inflammatory disease biotech Expedition Therapeutics is paying $17 million cash for licensing rights to an ...

The market for chronic obstructive pulmonary disease treatment devices is projected to witness substantial growth, fueled by ...

Treatment Devices Market is set to grow at a CAGR of 6.35% from 2025 to 2032. This surge is driven by rising COPD prevalence due to factors like tobacco smoking and air pollution, increased awareness, ...

Chronic Obstructive Pulmonary Disease (COPD) refers to a collection of lung diseases that are characterized by breathing difficulties. Credit: yodiyim/Shutterstock.com ...

A new report looking at each state’s rates of Chronic Obstructive Pulmonary Disease, better known as COPD, shows New Mexico ...

Chronic Obstructive Pulmonary Disease Part 1: Epidemiology, Etiology, Pathophysiology, and Diagnosis Gerald W. Staton, Jr., MD Disclosures September 01, 2009 0 ...

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015; (10 ...

Strict control of comorbidities in patients with chronic obstructive pulmonary disease decreases exacerbations, morbimortality, and avoids readmissions. An increasing number of women have the ...

Severe gum disease has been linked to the progression of chronic obstructive pulmonary disease, or COPD, but an understanding of how the connection plays out in the immune system remains unclear ...

Chronic obstructive pulmonary disease (COPD) is an assortment of lung disorders that includes:- chronic bronchitis emphysema chronic obstructive airways disease As the name suggests there is ...